Clinical trials, between science and financial and academic interests
Pierre Chirac
On May 22, the Lancet published a peer-reviewed article based on an analysis of 96,000 Covid patient files, which concluded that hydroxychloroquine was ineffective. A few days later, researchers published a letter questioning the methodology and data used by the Surgisphere company to develop this conclusion, and on June 4, the Lancet withdrew the article from publication. This was the beginning of what some people call "Lancetgate", or the "Surgisphere Scandal".
Beyond the frenzy of scientific publications triggered by the Covid-19 outbreak (47,000 in three months!), this event highlighted the questionable reliability of clinical trials. In September 2009, the scientific journal PloS Medicine argued that most trials of new drugs, including those supposedly authored by academic physicians, are subject to frequent manipulation. The title of their editorial clearly indicates scorn: Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger, and the piece specifically outlines the influence and power of drug manufacturers in the clinical research process. Yet the poor quality studies published by French hospital doctors on hydroxychloroquine, even with no link to pharmaceutical companies, show that the problem goes far beyond that of trials financed by 'Big Pharma'.
Pierre Chirac, pharmacist and editor of the journal Prescrire, presented his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation.
To cite this content :
Pierre Chirac, “Clinical trials, between science and financial and academic interests”, 8 octobre 2020, URL : https://msf-crash.org/en/conferences-debates/clinical-trials-between-science-and-financial-and-academic-interests
If you want to criticize or develop this content, you can find us on twitter or directly on our site.
Contribute
Daro Sulakauri
Opinion
No credit for Drs Knock
12/01/2009Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.
Giorgos Moutafis
Analysis
Postface à l’ouvrage "Médiator 150mg"
06/30/2010Ce texte est une postface au livre du Dr Irène Frachon Médiator, 150mg dont le sous-titre « Combien de morts ?», a été retiré à la suite d'une plainte du laboratoire Servier, producteur du médicaments incriminé. Rony Brauman y aborde la question du poids croissant des compagnies pharmaceutiques dans les décisions de santé publique.
Aurelie Baumel
Interview
Santé mondiale. L’évolution vers la privatisation
12/01/2014Pour Rony Brauman, la question de la santé globale se caractérise d'abord et avant tout par la circulation des agents infectieux et toxiques qui relève d'une action mondiale.
Past events
Conference
Another approach to well-being at work
12/09/2021 - 06:30 PM 08:30 PMThe members of the Crash were very happy to welcome you all to this new conference-debate with occupational psychologists Yves Clot and Jean-Yves Bonnefond, two of the authors of “Le prix du travail bien fait – La coopération conflictuelle dans les organisations” (Paris, La Découverte, 2021 ; co-written with Antoine Bonnemain and Mylène Zittoun).
msf
Conference
Book launch event - Violences extrêmes. Enquêter, secourir, juger République démocratique du Congo, Rwanda, Syrie
11/17/2021 - 06:30 PM 08:30 PMWe were very happy to welcome two authors of the book: sociologist (CNRS) and Crash scientific committee member Claudine Vidal, and Jean-Hervé Bradol, doctor, former President of the French section of MSF and current director studies at the Crash, for the launching event of the newly-published book “Violences extrêmes. Enquêter, secourir, juger République démocratique du Congo, Rwanda, Syrie” (Éditions de la Maison des sciences de l’homme, Paris 2021). The event was hosted by Rony Brauman.
Conference
Asylum and exile. A history of the distinction between migrants / refugees
04/12/2021 - 06:30 PM 08:30 PMOn April 12 2021 we had the great pleasure of hosting a virtual CRASH conference with political scientist and sociologist Karen Akoka, fresh from her publication in November of “Asylum and Exile. A History of the Refugee/Migrant Distinction" (La Découverte, 2020). The author described and analyzed the trajectory of OFPRA, the French institution founded in 1952 and responsible for granting refugee status; she provided an insight into how the history of the distinction between migrants and refugees was established in France.
Conference
Clinical trials, between science and financial and academic interests
10/08/2020 - 06:00 PM 08:00 PMPierre Chirac, pharmacist and editor of the journal Prescrire, presented his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation.
Conference
The quantification of needs
12/10/2020 - 06:00 PM 08:00 PMCombining historical research and ethnographic investigations, the Africanist historian Joël Glasman plunges us into the factory of the homo humanitarianus, the average individual, on the basis of which "needs" and aid projects today are assessed. This conversation took place on December 10th 2020, during a conference-debate at Crash.
Conference
Territories: the illusion of identity
12/16/2019 - 06:00 PM 08:00 PMConference-debate on Monday 16 December 2019, 6-8pm in the 1st floor meeting room at MSF, 14-34 avenue Jean Jaurès 75019 Paris. Streaming and simultaneous translation into English available.
Can we talk about the specificities of the Middle East, Iran or the Mediterranean without reducing these territories to a culture or religion? On December 16, 2019, the CRASH team organised a conference-debate with Jean-François Bayart, a French political scientist who has devoted his work to the sociology of the State and identity illusions.